已收盘 10-31 16:00:00 美东时间
+0.280
+0.51%
Bright Minds Biosciences announced it will present at two upcoming conferences: the Guggenheim Healthcare Innovation Conference on November 12, 2025, and the Jefferies Global Healthcare Conference in London on November 10, 2025. Live and archived webcasts will be available for the Guggenheim event. The company also granted stock options to purchase 43,000 common shares under their share option plan.
10-30 22:30
苏州瑞博生物技术股份有限公司(“瑞博生物”)及其子公司Ribocure Pharmaceuticals AB (“Ribocure”)共同宣布欧洲药品管理局(EMA)授予其小干扰RNA(siRNA)候选药物RBD1016孤儿药资格认定(Orphan Drug Designation, ODD),用于治疗丁型肝炎病毒(HDV)的感染。
10-24 17:02
https://www.marijuanamoment.net/psychedelics-show-promise-as-an-entirely-new-type-of-anti-inflammatory-treatment-research-suggests/
10-14 01:28
Mark Cuban says that the backing of President Donald Trump by Big Tech is more about staying ahead in the AI race than political alignment.
09-28 03:11
BTIG initiates coverage on Bright Minds Biosciences with a Buy rating, citing BMB‑101's potential and key Phase 2 data expected by the end of 2025
09-09 01:54
BTIG analyst Thomas Shrader initiates coverage on Bright Minds Biosciences (NASDAQ:DRUG) with a Buy rating and announces Price Target of $72.
09-08 18:10
https://www.marijuanamoment.net/military-to-start-testing-service-members-for-the-psychedelic-psilocin-memo-shows/
08-29 02:16
First concentrated, ready-to-dilute liquid glucagon available for diagnostic procedures SHIRLEY, N.Y., Aug. 27, 2025 /PRNewswire/ -- American Regent, Inc.® is pleased to announce the commerc...
08-27 20:35
Bright Minds Biosciences, a biotech company focused on developing selective 5-HT2 agonists for CNS disorders, will present at four upcoming conferences: the 36th International Epilepsy Congress in Lisbon, the Cantor Global Healthcare Conference, the H.C. Wainwright Global Investment Conference, and the Baird Global Healthcare Conference. Webcasts are available for the Cantor event. The company aims to address unmet medical needs in epilepsy, depr...
08-25 12:00
DUBLIN, Aug. 20, 2025 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) will host an investor webcast on Wednesday, August 27, 2025, at 4:30 p.m. EDT / 9:30 p.m. IST to provide an over...
08-21 04:15